Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

India's Bharat Biotech says regulatory steps taken for Brazil vaccine contract

1 minute read
1/2

FILE PHOTO: A man receives a Bharat Biotech's COVID-19 vaccine called COVAXIN, at a vaccination centre, in New Delhi, India, February 13, 2021. REUTERS/Adnan Abidi/File Photo/File Photo

BENGALURU, June 30 (Reuters) - India's Bharat Biotech said on Wednesday it followed a "step-by-step" approach for the regulatory approval and supply contract of its COVID-19 vaccine in Brazil, and that it has not received advance payments from the Brazilian health ministry.

Brazil's health minister said on Tuesday the country will suspend its $324 million contract for 20 million doses of Bharat Biotech's vaccine after whistleblowers went public with alleged irregularities in the deal. read more

Reporting by Anuron Kumar Mitra in Bengaluru, Editing by Sherry Jacob-Phillips

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters